+5,484.2%
NVDA vs CLSK
-86.0%
+5,570.2%
-66.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | CLSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -14.0% | -16.3% | +2.3% | -13.3% |
| 7D | -22.9% | -26.5% | +3.5% | -21.9% |
| 30D | -43.4% | -44.1% | +0.7% | -42.1% |
| 3M | -42.0% | -61.2% | +19.1% | -39.9% |
| 6M | -43.7% | -68.2% | +24.5% | -41.3% |
| YTD | -32.5% | -51.7% | +19.1% | -31.1% |
| 1Y | -30.3% | -50.0% | +19.7% | -29.1% |
| 3Y | +149.8% | +6.5% | +143.2% | +142.3% |
| 5Y | +282.2% | -72.8% | +355.1% | +273.4% |
| 10Y | +5,380.7% | -86.0% | +5,466.7% | +4,862.8% |
| All | +5,484.2% | -86.0% | +5,570.2% | +4,956.5% |
Cumulative growth
Daily Returns
Daily percentage return beside CLSK.
Daily Out/Under-Performance
Portfolio return minus CLSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CLSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded CLSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling